Exploring use of Altamira's RNA nanoparticles in conjunction with radiopharmaceutical cancer treatment Project collaboration partner will have option ...
The transcription factor regulatory network in Pseudomonas aeruginosa is complex and involves multiple regulators that respond to various environmental signals and physiological cues by regulating ...
Victoria's Container Deposit Scheme (CDS Vic) is an important part of the work that is transforming Victoria’s waste and recycling system. Victoria’s first-ever Regional circular economy plans have ...
The current human tissue-based study provides convincing evidence correlating hippocampal expressions of RNA guanine-rich G-quadruplexes with aging and with Alzheimer's Disease presence and severity.
NTxscribe benchtop system produces high integrity RNA in two hours to enable affordable personalized medicine at scale Nature’s Toolbox (NTx), a life sciences company developing next-generation ...
Fresh off of Oura revealing a feature that helps users identify a cold or flu, Circular has announced its Ring 2, a next-gen wearable with an Atrial Fibrilation detection algorithm approved by the ...
Smart ring maker Circular announced its next-gen Ring 2 with ECG (electrocardiogram) functionality and AFib (atrial fibrillation) detection at CES 2025 Unveiled on Sunday in Las Vegas. The ...
Just in time for CES 2025, Circular has lifted the curtain to reveal the new Circular Ring 2, a completely redesigned smart ring that offers two key features that no other smart ring, including ...
About 300 young people engaged in multiple fights in a Wānaka park last night. Otago Lakes area police said they were called to Dinosaur Park about midnight after reports of fights. "At least three ...
(“Altamira” or the “Company”) (OTCQB:CYTOF), a company dedicated to developing and commercializing RNA delivery technology for targets beyond the liver, today announced that its nanoparticle-based ...
In vitro experiments demonstrated successful ... offering its platform to biotech and pharma companies for use with circular RNA under the CycloPhore™ label, complementing its offerings for ...